Referencias:

• Ellis, S.G., Roubin, G.S., King, S.B., Douglas J.S., Jr., Weintraub, W.S., Thomas, R.G., Cox, W.R., Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty (1988) Circulation, 77, pp. 372-379
• Ellis, S.G., Coronary lesions at increased risk (1995) Am Heart J, 130, pp. 643-646
• Kasaoka, S., Tobis, J.M., Akiyama, T., Reimers, B., Di Mario, C., Wong, N.D., Colombo, A., Angiographic and intravascular ultrasound predictors of in-stent restenosis (1998) J Am Coll Cardiol, 32, pp. 1630-1635
• Kornowski, R., Mehran, R., Hong, M.K., Satler, L.F., Pichard, A.D., Kent, K.M., Mintz, G.S., Lansky, A.J., Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions (1998) Circulation, 97, pp. 1355-1361
• Kobayashi, Y., De Gregorio, J., Kobayashi, N., Akiyama, T., Reimers, B., Finci, L., Di Mario, C., Colombo, A., Stented segment length as an independent predictor of restenosis (1999) J Am Coll Cardiol, 34, pp. 651-659
• Kastrati, A., Elezi, S., Dirschinger, J., Hadamitzky, M., Neumann, F.J., Schomig, A., Influence of lesion length on restenosis after coronary stent placement (1999) Am J Cardiol, 83, pp. 1617-1622
• Hong, M.K., Park, S.W., Mintz, G.S., Lee, N.H., Lee, C.W., Kim, J.J., Park, S.J., Intravascular ultrasonic predictors of angiographic restenosis after long coronary stenting (2000) Am J Cardiol, 85, pp. 441-445
• Fischman, D.L., Leon, M.B., Baim, D.S., Schatz, R.A., Savage, M.P., Penn, I., Detre, K., Nobuyoshi, M., A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators (1994) N Engl J Med, 331, pp. 496-501
• Serruys, P.W., De Jaegere, P., Kiemeneij, F., Macaya, C., Rutsch, W., Heyndrickx, G., Emanuelsson, H., Materne, P., A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group (1994) N Engl J Med, 331, pp. 489-495. , (see comments)
• Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization (1997) N Engl J Med, 336, pp. 1689-1696
• Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein- IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (1998) Lancet, 352, pp. 87-92
• Serruys, P.W., Foley, D.P., Suttorp, M.J., Rensing, B.J., Suryapranata, H., Materne, P., Van den Bos, A., Rutsch, W., A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: Final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study (2002) J Am Coll Cardiol, 39, pp. 393-399

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------